T cell cross-priming by PD-L1+ type 1 conventional dendritic cells mediates the antitumor efficacy of a PD-L1×4-1BB bispecific antibody

Immunity · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles